ELEVATION ONCOLOGY

elevation-oncology-logo

Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Its lead candidate, seribantumab, which inhibits tumor growth driven by NRG1 fusions, is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion.

#SimilarOrganizations #People #Financial #Event #Website #More

ELEVATION ONCOLOGY

Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical

Founded:
2019-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.elevationoncology.com

Total Employee:
11+

Status:
Active

Contact:
(716) 371-1125

Email Addresses:
[email protected]

Total Funding:
147.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

alto-neuroscience-logo

Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

elpiscience-biopharmaceuticals-logo

Elpiscience Biopharmaceuticals

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

resilience-logo

Resilience

Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.

roivant-sciences-logo

Roivant Sciences

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.


Current Advisors List

richard-gaster_image

Richard Gaster Board Member @ Elevation Oncology
Board_member
2020-11-01

not_available_image

Andrew Phillips Board Member @ Elevation Oncology
Board_member
2020-11-01

Current Employees Featured

david-dornan_image

David Dornan
David Dornan Chief Scientific Officer @ Elevation Oncology
Chief Scientific Officer
2022-03-01

shawn-leland_image

Shawn Leland
Shawn Leland Founder and Chief Executive Officer @ Elevation Oncology
Founder and Chief Executive Officer
2020-11-01

Founder


shawn-leland_image

Shawn Leland

Stock Details


Company's stock symbol is NASDAQ:ELEV

Investors List

k2-healthventures_image

K2 HealthVentures

K2 HealthVentures investment in Post-IPO Debt - Elevation Oncology

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Elevation Oncology

venbio_image

venBio Partners

venBio Partners investment in Series B - Elevation Oncology

qiming-venture-partners-usa_image

Qiming Venture Partners USA

Qiming Venture Partners USA investment in Series B - Elevation Oncology

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Elevation Oncology

aisling-capital_image

Aisling Capital

Aisling Capital investment in Series B - Elevation Oncology

driehaus-capital-management_image

Driehaus Capital Management

Driehaus Capital Management investment in Series B - Elevation Oncology

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Series B - Elevation Oncology

bvf-partners_image

BVF Partners

BVF Partners investment in Series B - Elevation Oncology

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series B - Elevation Oncology

Official Site Inspections

http://www.elevationoncology.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.87 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Elevation Oncology" on Search Engine